Results 121 to 130 of about 10,191,051 (291)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma

, 2013
Emilia L Lim,1 Marco A Marra1,21Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; 2Department of Medical Genetics, University of British Columbia, Vancouver, BC, CanadaAbstract: B-cell non-Hodgkin lymphomas ...
Marra MA, Lim EL
core  

Composite Lymphoma: EBV-positive Classic Hodgkin Lymphoma and Peripheral T-cell Lymphoma A Case Report

, 2009
Composite lymphomas are rare and defined as hematopoietic neoplasms with more than I malignant lymphomatous clone showing different phenotypic features.
Berg, Anke Van Den, Weiss, Lawrence M., Bacchi, Carlos E., Van Den Berg, Anke; id_orcid, Gualco, Gabriela, Van Den Berg, Anke, Chioato, Lucimara   +6 more
core   +1 more source

Endocrine therapy‐induced cancer‐related fatigue in hormone‐dependent malignancies: Mechanisms, impact, and management strategies

Precision Medical Sciences, EarlyView.
Multipathway schematic of endocrine therapy–induced cancer‐related fatigue. Endocrine interventions trigger four interacting mechanisms—neuroendocrine dysregulation, systemic inflammation, energy‐metabolic failure, and psycho‐behavioral amplification—that culminate in the multidimensional CRF phenotype.
Jiajing Jiang, Jun Lu, Sen Qin, Ruzhou Chen, Qiuchen Zhang, Lvqi He, Yubei Li, Jingyao Yan   +7 more
wiley   +1 more source

Effects of proton therapy on the tumor immune system and clinical implications: A review

Precision Radiation Oncology, EarlyView.
Proton therapy is a novel radiotherapy technique. We review four aspects of proton therapy: application in various tumors, effects on the tumor immune system, combination with other therapies, and future challenges. By presenting these aspects in this review, we aim to inspire clinical interventions.
Rundong Liu, Mei Tao, Min Fu, Yingjia Hu, Zhen Tao, Guangyuan Hu   +5 more
wiley   +1 more source

Diagnostic criteria and new therapeutic options for patients diagnosed with non-Hodgkin lymphoma

Archivo Médico de Camagüey, 2019
Background: malignant haemopathies increase their incidence and proliferation within the population, among them the lymphoproliferative syndrome occupies an important place, it is a group of disorders of clonal origin, which affects the lymphoid cells ...
Yaimé Moreno-Laguard, Leonardo Laguna-Salvia, José Ignacio Larquin-Comet, Cira Cecilia León-Ramentol, Yadier Fermin Hernandez-Soler, Maurice José González-Basulto   +5 more
doaj  

Correlações entre histopatologia, imuno-histoquímica e imunofenotipagem por citometria de fluxo no diagnóstico de linfomas não-hodgkin de células b maduras, HU-UFSC, 1999-2007 [PDF]

, 2010
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Sabaini, Carlos Sitta
core  

MR‐Linac Successfully Guided the Treatment of a Free‐Moving Mesenteric Mass

Precision Radiation Oncology, EarlyView.
This case demonstrated that a mesenteric tumor could move significantly day‐to‐day in all directions with large volume change. MR‐Linac with online adaptive capability provided a superior platform to treat mobile target with significantly reduced normal tissue exposure to radiation .
Xin Wang, Tze Yee Lim, He Wang, Bouthaina Shbib Dabaja, Jinzhong Yang   +4 more
wiley   +1 more source

Can Burkitt's Lymphoma and Hodgkin's Lymphoma occur in siblings simultaneously?

The Turkish Journal of Pediatrics, 2015
Familial clustering of Hodgkin lymphoma (HL) and increased risk of developing disease among the siblings has been reported earlier. Usually familial lymphoma in sibling pairs occurs in the pairs of either non-Hodgkin lymphoma or HL.
Meriç Kaymak Cihan, Olcay Kandemir, Klara Dalva, Neriman Sarı, Nilgün Kurucu, İnci Ergürhan İlhan   +5 more
doaj  

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide

B-ENT, 2015
Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide. The paranasal sinuses are rarely the site of malignancy, especially non-Hodgkin lymphoma.
K. Broes, L. Van Ginderachter, E. Joosens, A. Maes, K. Theunissen, S. Schepers, K. Deben, J. Claes, J. Mebis, T. Cox   +9 more
doaj   +2 more sources